ADVERTISEMENT

European Biotechnology

1 / 4
EBM 3.2026 Autumn_cover

The autumn issue of European Biotechnology magazine asks what happens when biotech leaves Earth. Our cover story explores how microgravity could help researchers study disease, improve drug formulations … more ➔

Get a free sample copy | Abo
2 / 4

The summer issue of European Biotechnology Magazine showcases the latest developments in drug delivery and RNA technologies. This issue features a list of eight venture capital firms to watch in 2026. … more ➔

Get a free sample copy | Abo
3 / 4

The Spring 2026 issue of European Biotechnology Magazine presents a list of start-ups to watch in 2026 and explores other fascinating topics such as: Can biotechnology finally fix infertility? Can … more ➔

Get a free sample copy | Abo
4 / 4
EB425_Cover

Europe is losing much of its expertise in deep tech and life sciences to the US. To prevent another generation of innovation from being lost, Europe must close the funding gaps. more ➔

Get a free sample copy | Abo

ADVERTISEMENT

ADVERTISEMENT

Sponsored Publications

1 / 3
Team Invitris
artificial intelligence

Closing AI medicine’s manufacturing gap

At the IZB in Martinsried, Invitris is developing a cell-free platform to turn ­digital sequences into proteins, antibodies and phages within hours. CEO Patrick Grossmann explains why AI is shifting … more ➔

2 / 3
IDT Biologika
CRO & CDMO

From development to commercial reality

Helping biopharmaceutical innovators build scalable, manufacturable, and commercially viable processes from the start. more ➔

3 / 3
Professor Jacob George, Chief Medical and Scientific Officer at the MHRA presenting his keynote speech at Phacilitate Advanced Therapies Europe, 2026
Cell & Gene Therapy

Europe’s CGT advantage at risk

Industry leaders at Advanced Therapies Europe 2026 warned that Europe must tackle barriers across commercialisation, regulation, reimbursement, manufacturing and patient access to retain its global … more ➔

APPOINTMENTS

all appointments

ADVERTISEMENT

All news
newsletter_link

EVENT

Eventbild-heidelberg-2026-boehmert[21]
November 3 @ 09:00 - 13:00in Heidelberg, Germany

IP Seminar for Life Sciences & Chemistry

How can pharmaceutical, biotech and chemical companies effectively protect innovation in a rapidly evolving European patent landscape? BOEHMERT & BOEHMERT's complimentary IP Seminar in Heidelberg explores recent developments at the Unified Patent Court (UPC), the Unitary Patent system and the European Patent Office, highlighting practical strategie ... ➔